Wnt5a signaling increases IL-12 secretion by human dendritic cells and enhances IFN-γ production by CD4+ T cells

Immunology Letters

Volumn 162, Issue 1, 2015, Pages 188-199

  Valencia, Jaris ^a   Martínez, Víctor G ^a   Hidalgo, Laura ^a   Hernández López, Carmen ^a   Canseco, Noelia M ^a   Vicente, Ángeles ^a   Varas, Alberto ^a   Sacedón, Rosa ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

DCs; IFN ; IL 10; IL 12; T cell; Wnt

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; FRIZZLED PROTEIN; GAMMA INTERFERON; INTERLEUKIN 12; LIGAND; WNT5A PROTEIN; CYTOKINE; ONCOPROTEIN; TOLL LIKE RECEPTOR; WNT PROTEIN; WNT11 PROTEIN, HUMAN; WNT4 PROTEIN; WNT5A PROTEIN, HUMAN;

ARTICLE; CD4+ T LYMPHOCYTE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DEVELOPMENTAL STAGE; ENDOCYTOSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; PARACRINE SIGNALING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TH1 CELL; WNT5A GENE; AUTOCRINE EFFECT; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION;

AUTOCRINE COMMUNICATION; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12; LIGANDS; PROTO-ONCOGENE PROTEINS; RECEPTORS, WNT; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; WNT PROTEINS; WNT4 PROTEIN;

EID: 84908440134     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2014.08.015     Document Type: Article

References (71)

1. Reis e Sousa C. Dendritic cells in a mature age. Nat Rev Immunol 2006, 6:476-483.
2. Palucka K., Banchereau J. Cancer immunotherapy via dendritic cells. Nat Rev Cancer 2012, 12:265-277.
3. Geissmann F., Manz M.G., Jung S., Sieweke M.H., Merad M., Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327:656-661.
4. Manicassamy S., Pulendran B. Dendritic cell control of tolerogenic responses. Immunol Rev 2011, 241:206-227.
5. Schmidt S.V., Nino-Castro A.C., Schultze J.L. Regulatory dendritic cells: there is more than just immune activation. Front Immunol 2012, 3:274.
6. Mayer C.T., Berod L., Sparwasser T. Layers of dendritic cell-mediated T cell tolerance, their regulation and the prevention of autoimmunity. Front Immunol 2012, 3:183.
7. van Amerongen R., Nusse R. Towards an integrated view of Wnt signaling in development. Development 2009, 136:3205-3214.
8. Wend P., Holland J.D., Ziebold U., Birchmeier W. Wnt signaling in stem and cancer stem cells. Semin Cell Dev Biol 2010, 21:855-863.
9. Clevers H., Nusse R. Wnt/beta-catenin signaling and disease. Cell 2012, 149:1192-1205.
10. Polakis P. Wnt signaling in cancer. Cold Spring Harb Perspect Biol 2012, 4.
11. Hendrickx M., Leyns L. Non-conventional Frizzled ligands and Wnt receptors. Dev Growth Differ 2008, 50:229-243.
12. Tamai K., Semenov M., Kato Y., Spokony R., Liu C., Katsuyama Y., et al. LDL-receptor-related proteins in Wnt signal transduction. Nature 2000, 407:530-535.
13. Komiya Y., Habas R. Wnt signal transduction pathways. Organogenesis 2008, 4:68-75.
14. van Amerongen R. Alternative Wnt pathways and receptors. Cold Spring Harb Perspect Biol 2012, 4.
15. Angers S., Moon R.T. Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol 2009, 10:468-477.
16. Valencia J., Hernandez-Lopez C., Martinez V.G., Hidalgo L., Zapata A.G., Vicente A., et al. Wnt5a skews dendritic cell differentiation to an unconventional phenotype with tolerogenic features. J Immunol 2011, 187:4129-4139.
17. Bergenfelz C., Medrek C., Ekstrom E., Jirstrom K., Janols H., Wullt M., et al. Wnt5a induces a tolerogenic phenotype of macrophages in sepsis and breast cancer patients. J Immunol 2012, 188:5448-5458.
18. Blumenthal A., Ehlers S., Lauber J., Buer J., Lange C., Goldmann T., et al. The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation. Blood 2006, 108:965-973.
19. Gudjonsson J.E., Johnston A., Stoll S.W., Riblett M.B., Xing X., Kochkodan J.J., et al. Evidence for altered Wnt signaling in psoriatic skin. J Invest Dermatol 2010, 130:1849-1859.
20. Sen M., Lauterbach K., El-Gabalawy H., Firestein G.S., Corr M., Carson D.A. Expression and function of wingless and frizzled homologs in rheumatoid arthritis. Proc Natl Acad Sci U S A 2000, 97:2791-2796.
21. Kim J., Kim J., Kim D.W., Ha Y., Ihm M.H., Kim H., et al. Wnt5a induces endothelial inflammation via beta-catenin-independent signaling. J Immunol 2010, 185:1274-1282.
22. Rauner M., Stein N., Winzer M., Goettsch C., Zwerina J., Schett G., et al. WNT5A is induced by inflammatory mediators in bone marrow stromal cells and regulates cytokine and chemokine production. J Bone Miner Res 2012, 27:575-585.
23. Pereira C., Schaer D.J., Bachli E.B., Kurrer M.O., Schoedon G. Wnt5A/CaMKII signaling contributes to the inflammatory response of macrophages and is a target for the antiinflammatory action of activated protein C and interleukin-10. Arterioscler Thromb Vasc Biol 2008, 28:504-510.
24. Kurayoshi M., Oue N., Yamamoto H., Kishida M., Inoue A., Asahara T., et al. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res 2006, 66:10439-10448.
25. Huang C.L., Liu D., Nakano J., Ishikawa S., Kontani K., Yokomise H., et al. Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor - an expression in non-small-cell lung cancer. J Clin Oncol 2005, 23:8765-8773.
26. Pukrop T., Klemm F., Hagemann T., Gradl D., Schulz M., Siemes S., et al. Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. Proc Natl Acad Sci U S A 2006, 103:5454-5459.
27. Oderup C., LaJevic M., Butcher E.C. Canonical and noncanonical Wnt proteins program dendritic cell responses for tolerance. J Immunol 2013, 190:6126-6134.
28. Bilkovski R., Schulte D.M., Oberhauser F., Mauer J., Hampel B., Gutschow C., et al. Adipose tissue macrophages inhibit adipogenesis of mesenchymal precursor cells via wnt-5a in humans. Int J Obes (Lond) 2011, 35:1450-1454.
29. Martinez V.G., Hernandez-Lopez C., Valencia J., Hidalgo L., Entrena A., Zapata A.G., et al. The canonical BMP signaling pathway is involved in human monocyte-derived dendritic cell maturation. Immunol Cell Biol 2011, 89:610-618.
30. Valencia J., Hernandez-Lopez C., Martinez V.G., Hidalgo L., Zapata A.G., Vicente A., et al. Transient beta-catenin stabilization modifies lineage output from human thymic CD34+CD1a-progenitors. J Leukoc Biol 2010, 87:405-414.
31. Tickenbrock L., Schwable J., Strey A., Sargin B., Hehn S., Baas M., et al. Wnt signaling regulates transendothelial migration of monocytes. J Leukoc Biol 2006, 79:1306-1313.
32. Maiti G., Naskar D., Sen M. The Wingless homolog Wnt5a stimulates phagocytosis but not bacterial killing. Proc Natl Acad Sci U S A 2012, 109:16600-16605.
33. Lehtonen A., Ahlfors H., Veckman V., Miettinen M., Lahesmaa R., Julkunen I. Gene expression profiling during differentiation of human monocytes to macrophages or dendritic cells. J Leukoc Biol 2007, 82:710-720.
34. Cheng C.W., Smith S.K., Charnock-Jones D.S. Wnt-1 signaling inhibits human umbilical vein endothelial cell proliferation and alters cell morphology. Exp Cell Res 2003, 291:415-425.
35. Wu B., Crampton S.P., Hughes C.C. Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity 2007, 26:227-239.
36. Bansal K., Trinath J., Chakravortty D., Patil S.A., Balaji K.N. Pathogen-specific TLR2 protein activation programs macrophages to induce Wnt-beta-catenin signaling. J Biol Chem 2011, 286:37032-37044.
37. Schaale K., Neumann J., Schneider D., Ehlers S., Reiling N. Wnt signaling in macrophages: augmenting and inhibiting mycobacteria-induced inflammatory responses. Eur J Cell Biol 2011, 90:553-559.
38. Keeble T.R., Halford M.M., Seaman C., Kee N., Macheda M., Anderson R.B., et al. The Wnt receptor Ryk is required for Wnt5a-mediated axon guidance on the contralateral side of the corpus callosum. J Neurosci 2006, 26:5840-5848.
39. Lu W., Yamamoto V., Ortega B., Baltimore D. Mammalian Ryk is a Wnt coreceptor required for stimulation of neurite outgrowth. Cell 2004, 119:97-108.
40. Wouda R.R., Bansraj M.R., de Jong A.W., Noordermeer J.N., Fradkin L.G. Src family kinases are required for WNT5 signaling through the Derailed/RYK receptor in the Drosophila embryonic central nervous system. Development 2008, 135:2277-2287.
41. Fradkin L.G., Dura J.M., Noordermeer J.N. Ryks: new partners for Wnts in the developing and regenerating nervous system. Trends Neurosci 2010, 33:84-92.
42. Lyu J., Yamamoto V., Lu W. Cleavage of the Wnt receptor Ryk regulates neuronal differentiation during cortical neurogenesis. Dev Cell 2008, 15:773-780.
43. Povinelli B.J., Nemeth M.J. Wnt5a regulates hematopoietic stem cell proliferation and repopulation through the Ryk receptor. Stem Cells 2014, 32:105-115.
44. O'Connell M.P., French A.D., Leotlela P.D., Weeraratna A.T. Assaying Wnt5A-mediated invasion in melanoma cells. Methods Mol Biol 2008, 468:243-253.
45. Ripka S., Konig A., Buchholz M., Wagner M., Sipos B., Kloppel G., et al. WNT5A - target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer. Carcinogenesis 2007, 28:1178-1187.
46. Romanowska M., Evans A., Kellock D., Bray S.E., McLean K., Donandt S., et al. Wnt5a exhibits layer-specific expression in adult skin, is upregulated in psoriasis, and synergizes with type 1 interferon. PLoS ONE 2009, 4:e5354.
47. Reischl J., Schwenke S., Beekman J.M., Mrowietz U., Sturzebecher S., Heubach J.F. Increased expression of Wnt5a in psoriatic plaques. J Invest Dermatol 2007, 127:163-169.
48. Ouchi N., Higuchi A., Ohashi K., Oshima Y., Gokce N., Shibata R., et al. Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 2010, 329:454-457.
49. Schulte D.M., Muller N., Neumann K., Oberhauser F., Faust M., Gudelhofer H., et al. Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects. PLoS ONE 2012, 7:e32437.
50. Shan M., Gentile M., Yeiser J.R., Walland A.C., Bornstein V.U., Chen K., et al. Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals. Science 2013, 342:447-453.
51. Deng J., Miller S.A., Wang H.Y., Xia W., Wen Y., Zhou B.P., et al. Hung MC. beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer. Cancer Cell 2002, 2:323-334.
52. Du Q., Zhang X., Cardinal J., Cao Z., Guo Z., Shao L., et al. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells. Cancer Res 2009, 69:3764-3771.
53. Dai C., Wen X., He W., Liu Y. Inhibition of proinflammatory RANTES expression by TGF-beta1 is mediated by glycogen synthase kinase-3beta-dependent beta-catenin signaling. J Biol Chem 2011, 286:7052-7059.
54. Die L., Yan P., Jun Jiang Z., Min Hua T., Cai W., Xing L. Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts. Mol Immunol 2012, 52:38-49.
55. Jiang A., Bloom O., Ono S., Cui W., Unternaehrer J., Jiang S., et al. Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity 2007, 27:610-624.
56. Beurel E., Michalek S.M., Jope R.S. Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol 2010, 31:24-31.
57. Rodionova E., Conzelmann M., Maraskovsky E., Hess M., Kirsch M., Giese T., et al. GSK-3 mediates differentiation and activation of proinflammatory dendritic cells. Blood 2007, 109:1584-1592.
58. Ono T., Yanagawa Y., Iwabuchi K., Nonomura K., Onoe K. Glycogen synthase kinase 3 activity during development of bone marrow-derived dendritic cells (DCs) essential for the DC function to induce T helper 2 polarization. Immunology 2007, 122:189-198.
59. Manicassamy S., Reizis B., Ravindran R., Nakaya H., Salazar-Gonzalez R.M., Wang Y.C., et al. Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science 2010, 329:849-853.
60. Mikels A.J., Nusse R. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol 2006, 4:e115.
61. Hack K., Reilly L., Proby C., Fleming C., Leigh I., Foerster J. Wnt5a inhibits the CpG oligodeoxynucleotide-triggered activation of human plasmacytoid dendritic cells. Clin Exp Dermatol 2012, 37:557-561.
62. Janda C.Y., Waghray D., Levin A.M., Thomas C., Garcia K.C. Structural basis of Wnt recognition by Frizzled. Science 2012, 337:59-64.
63. Liang H., Chen Q., Coles A.H., Anderson S.J., Pihan G., Bradley A., et al. Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell 2003, 4:349-360.
64. Ying J., Li H., Chen Y.W., Srivastava G., Gao Z., Tao Q. WNT5A is epigenetically silenced in hematologic malignancies and inhibits leukemia cell growth as a tumor suppressor. Blood 2007, 110:4130-4132.
65. Lee Y.S., Lee K.A., Yoon H.B., Yoo S.A., Park Y.W., Chung Y., et al. The Wnt inhibitor secreted Frizzled-Related Protein 1 (sFRP1) promotes human Th17 differentiation. Eur J Immunol 2012, 42:2564-2573.
66. Yu Q., Sharma A., Oh S.Y., Moon H.G., Hossain M.Z., Salay T.M., et al. T cell factor 1 initiates the T helper type 2 fate by inducing the transcription factor GATA-3 and repressing interferon-gamma. Nat Immunol 2009, 10:992-999.
67. Notani D., Gottimukkala K.P., Jayani R.S., Limaye A.S., Damle M.V., Mehta S., et al. Global regulator SATB1 recruits beta-catenin and regulates T(H)2 differentiation in Wnt-dependent manner. PLoS Biol 2010, 8:e1000296.
68. Xue H.H., Zhao D.M. Regulation of mature T cell responses by the Wnt signaling pathway. Ann N Y Acad Sci 2012, 1247:16-33.
69. Gattinoni L., Zhong X.S., Palmer D.C., Ji Y., Hinrichs C.S., Yu Z., et al. Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells. Nat Med 2009, 15:808-813.
70. Driessens G., Zheng Y., Locke F., Cannon J.L., Gounari F., Gajewski T.F. Beta-catenin inhibits T cell activation by selective interference with linker for activation of T cells-phospholipase C-gamma1 phosphorylation. J Immunol 2011, 186:784-790.
71. van Loosdregt J., Fleskens V., Tiemessen M.M., Mokry M., van Boxtel R., Meerding J., et al. Canonical Wnt signaling negatively modulates regulatory T cell function. Immunity 2013, 39:298-310.